← All stocks

Moderna

MRNA Scheduled selling only

CIK 0001682852 #318 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$64.63M

$278.86K on a plan · $64.36M straight out of an exercise

Sold at will

$0.00

0 of 19 sales

Net

−$64.63M

$0.00 against sales at will

By person

12 insiders · 21 transactions

1,362×

Stéphane Bancel holds 1,362 times base salary in stock. $2.29B of shares against $1.68M in salary for 2025.

Salary from the company's own proxy. The shares are what Stéphane Bancel last reported holding, valued at $146.07, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bancel Stephane

Chief Executive Officer

—

$28.72M (4) scheduled

−$28.72M

15,650,946

3.92%

$2.29B

+7.7%

Hoge Stephen

President

—

$28.43M (6) scheduled

−$28.43M

1,718,078

0.4303%

$250.96M

+7.4%

Mock James M

Chief Financial Officer

—

$4.69M (2) scheduled

−$4.69M

59,375

0.0149%

$8.67M

+577.3%

Klinger Shannon Thyme

Chief Legal Officer

—

$1.39M (3) scheduled

−$1.39M

81,340

0.0204%

$11.88M

+326.1%

AFEYAN NOUBAR

Director

—

$1.14M (2) scheduled

−$1.14M

3,924

0.0010%

$573.18K

0.0%

Hussain Abbas

Director

—

$278.86K (2) scheduled

−$278.86K

12,066

0.0030%

$1.76M

—

SAGAN PAUL

Director

—

312,027

0.0782%

$45.58M

+11.3%

Nader Francois

Director

—

32,781

0.0082%

$4.79M

+59.1%

NABEL ELIZABETH G

Director

—

19,317

0.0048%

$2.82M

+817.7%

Horning Sandra

Director

—

18,585

0.0047%

$2.71M

+1,254%

Rubenstein David M.

Director

—

9,643

0.0024%

$1.41M

—

Tallett Elizabeth E

Director

—

4,761

0.0012%

$695.44K

+577.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Hussain Abbas

1 May 2026

Director

Sold on a plan

5,682

$46.63

$264.95K

Hussain Abbas

9 Dec 2025

Director

Sold on a plan

504

$27.60

$13.91K

Show all 21 transactions →

What was left out

Form 4 filings counted 64

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 17

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,498,345

History held since 13 Dec 2018